In AD Apolipoprotein E (ApoE) knockout mice, rosiglitazone increased mitochondrial biogenesis as demonstrated by the induction of both oestrogen-stimulated related receptor alpha (ESRRA) mRNA and mtDNA copy number and improved glucose utilization [147]. Here, APOE is linked to Alzheimer disease.